Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-03-20 @ 3:19 AM
Study NCT ID:
NCT01045018
Status:
COMPLETED
Last Update Posted:
2010-01-08
First Post:
2009-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis
Sponsor:
EMET Pharmaceuticals, LLC
Organization: